These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38589612)

  • 1. Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis.
    Vahabi Dastjerdi M; Sheibani S; Taheri M; Hezarcheshmeh FK; Jahangirian J; Jazayeri M; Hosseinirad H; Doohandeh T; Valizadeh R
    Arch Gynecol Obstet; 2024 Jun; 309(6):2323-2338. PubMed ID: 38589612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of ovarian injection of autologous platelet rich plasma in patients with poor ovarian responder: a systematic review and meta-analysis.
    Li X; Liu H; Lin G; Xu L
    Front Endocrinol (Lausanne); 2023; 14():1292168. PubMed ID: 38155954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria.
    Farimani M; Nazari A; Mohammadi S; Anvari Aliabad R
    Reprod Biol Endocrinol; 2021 Sep; 19(1):137. PubMed ID: 34496887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis.
    Éliás M; Kónya M; Kekk Z; Turan C; das Virgens IPA; Tóth R; Keszthelyi M; Hegyi P; Várbíró S; Sipos M
    J Ovarian Res; 2024 May; 17(1):104. PubMed ID: 38760869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intraovarian platelet-rich plasma injection on IVF outcomes in women with poor ovarian response: the PROVA randomized controlled trial.
    Herlihy NS; Cakiroglu Y; Whitehead C; Reig A; Tiras B; Scott RT; Seli E
    Hum Reprod; 2024 May; ():. PubMed ID: 38725194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraovarian platelet-rich plasma injection and IVF outcomes in patients with poor ovarian response: a double-blind randomized controlled trial.
    Barrenetxea G; Celis R; Barrenetxea J; Martínez E; De Las Heras M; Gómez O; Aguirre O
    Hum Reprod; 2024 Apr; 39(4):760-769. PubMed ID: 38423539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous platelet-rich plasma for assisted reproduction.
    Vaidakis D; Papapanou M; Siristatidis CS
    Cochrane Database Syst Rev; 2024 Apr; 4(4):CD013875. PubMed ID: 38682756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study.
    Melo P; Navarro C; Jones C; Coward K; Coleman L
    J Assist Reprod Genet; 2020 Apr; 37(4):855-863. PubMed ID: 32030554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP).
    Cakiroglu Y; Yuceturk A; Karaosmanoglu O; Kopuk SY; Korun ZEU; Herlihy N; Scott RT; Tiras B; Seli E
    Aging (Albany NY); 2022 Mar; 14(6):2513-2523. PubMed ID: 35320118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of platelet rich plasma on women with poor ovarian response: a systematic review and meta-analysis.
    Wu L; Su F; Luo P; Dong Q; Ma M; Ye G
    Platelets; 2024 Dec; 35(1):2292612. PubMed ID: 38214306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-ovarian infusion of autologous platelet-rich plasma in women with poor ovarian reserve: A before and after study.
    Hosseinisadat R; Farsi Nejad A; Mohammadi F
    Eur J Obstet Gynecol Reprod Biol; 2023 Jan; 280():60-63. PubMed ID: 36403398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ovarian response parameters and the synergistic effect of assisted reproduction of poor ovarian response treated with platelet rich plasma: systematic review and meta-analysis.
    Li W; Xu J; Deng D
    BMC Womens Health; 2024 Apr; 24(1):263. PubMed ID: 38678276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency.
    Cakiroglu Y; Saltik A; Yuceturk A; Karaosmanoglu O; Kopuk SY; Scott RT; Tiras B; Seli E
    Aging (Albany NY); 2020 Jun; 12(11):10211-10222. PubMed ID: 32507764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency.
    Aflatoonian A; Lotfi M; Saeed L; Tabibnejad N
    Reprod Sci; 2021 Jul; 28(7):2050-2059. PubMed ID: 33683669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma.
    Sills ES; Rickers NS; Li X; Palermo GD
    Gynecol Endocrinol; 2018 Sep; 34(9):756-760. PubMed ID: 29486615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve.
    Lunding SA; Pors SE; Kristensen SG; Landersoe SK; Jeppesen JV; Flachs EM; Pinborg A; Macklon KT; Pedersen AT; Andersen CY; Andersen AN
    Hum Reprod; 2019 Oct; 34(10):1924-1936. PubMed ID: 31593582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
    van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
    Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
    Lensen SF; Wilkinson J; Leijdekkers JA; La Marca A; Mol BWJ; Marjoribanks J; Torrance H; Broekmans FJ
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012693. PubMed ID: 29388198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
    Ngwenya O; Lensen SF; Vail A; Mol BWJ; Broekmans FJ; Wilkinson J
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD012693. PubMed ID: 38174816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Ovarian Reserve Tests and Age in the Prediction of Poor Ovarian Response to Controlled Ovarian Stimulation-A Real-World Data Analysis of 89,002 Patients.
    Wang X; Jin L; Mao YD; Shi JZ; Huang R; Jiang YN; Zhang CL; Liang XY
    Front Endocrinol (Lausanne); 2021; 12():702061. PubMed ID: 34526967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.